For research use only
| Cat No. | ABC-X0018C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Lymphocyte |
| Species | Human |
| Host Cell | BAF3 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Storage | Liquid Nitrogen |
The AKT1 (K39R) BAF3 cell line is an important model for studying the PI3K/AKT signaling pathway, facilitating functional screening and drug research.
Human AKT1 (K39R) BAF3 Cell Line is a genetically engineered model derived from selected murine Ba/F3 parental cell line based on customers’ requirement. AKT1 (K39R) BAF3 mutant cell line is generated by stable integration of exogenous human AKT1 gene harboring the K39R point mutation into Ba/F3 host cells using optimized transduction of lentiviral vectors.
Target
AKT1 is a serine/threonine kinase central to cell survival, growth, and metabolism through the PI3K/AKT/mTOR pathway. The K39R mutation, located within the pleckstrin homology (PH) domain, is a kinase-inactivating substitution used to investigate dominant-negative AKT signaling. It serves as a useful tool to dissect the functional relevance of AKT1 activity in growth factor-mediated pathways. AcceGen offers generation of stable overexpression and kinase-dead mutant cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0018C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocyte |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO₂ |
| Source Organ | Lymphatic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | BAF3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The AKT1 (K39R) BAF3 Cell Line serves as a powerful tool to investigate AKT1 loss-of-function mechanisms and pathway modulation. This model enables mechanistic studies of PI3K/AKT signaling blockade, IL-3 dependence, and drug response under kinase-inhibited conditions. It is utilized for functional screening of PI3K pathway inhibitors and negative regulatory elements in oncogenic signaling.